-- Health care stocks declined Thursday afternoon, with the NYSE Health Care Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.7%.
The iShares Biotechnology ETF (IBB) fell 1.9%.
In corporate news, Thermo Fisher Scientific (TMO) raised its full-year outlook on Thursday as Q1 results came in stronger than expected, even as organic growth fell short of analysts' estimates. Its shares fell 10.9%.
Fortescue (ASX:FMG) reported total iron ore shipments of 48.4 million wet metric tonnes (wmt) during the third quarter ended March 31, according to a Friday Australian bourse filing.The company recorded iron ore shipments of 46.1 million wmt for the quarter ended March 31, 2025, per the filing.Total ore mined during the quarter increased to 59.5 million wmt from 55.5 million wmt in the quarter ended March 31, 2025, while ore processed rose slightly to 47.8 million wmt from 47.6 million wmt in the same period, the filing said.The company maintained its fiscal year 2026 guidance of 195 million to 205 million tonnes of iron ore shipments, energy capital expenditure of about $300 million, and net operating capital expenditure of roughly $400 million.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month price target by $13 to $47, using a forward P/E of 15.6x our 2027 EPS estimate, a premium to the five-year historical average, as an EPS and market recovery more than offset weak margins and macroeconomic uncertainty. We raise our 2026 EPS estimate by $0.10 to $1.76 and our 2027 estimate by $0.57 to $3.02. KNX has demonstrated operational progress through seven straight quarters of improving tractor utilization, meaningful cost structure improvements, and advantages from its scale and diversified brand platform. However, the stock's valuation appears stretched, at 46% above its five-year average forward P/E multiple. This premium seems difficult to justify given Q1's weak performance: earnings declined Y/Y, margins remained weak, and revenue grew just 1%. While we anticipate strong EPS growth in 2026-2027, this largely represents a rebound from depressed levels rather than expansion into new territory, and we do not foresee earnings returning to the peak 2021-2022 levels in the near term.
Fortescue's (ASX:FMG) board approved an investment of $680 million to develop new green energy infrastructure in the Pilbara region in Western Australia as part of a broader $6.2 billion decarbonization program, according to a Friday Australian bourse filing.The company will develop the 200-megawatt (MW) Pilbara Green Energy Project, to be completed by 2028, with a pathway to multi-gigawatt expansion beyond 2030, the filing said.By 2028, Fortescue's previously announced green grid will comprise 1.2 gigawatts of solar energy, 600 MW of wind energy, 4 gigawatt-hours to 5 gigawatt-hours of battery storage, and 620 kilometers of transmission lines, per the filing.